# Psilocybin Therapy for Psychological Distress in Palliative Patients

> **NCT06782724** · PHASE2 · RECRUITING · sponsor: **University Medical Center Groningen** · enrollment: 108 (estimated)

## Conditions studied

- COPD (Chronic Obstructive Pulmonary Disease)
- ALS (Amyotrophic Lateral Sclerosis)
- MS (Multiple Sclerosis)
- Major Depressive Disorder (MDD)
- Atypical Parkinson Disease

## Interventions

- **DRUG:** Psilocybin therapy

## Key facts

- **NCT ID:** NCT06782724
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2026-05-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06782724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06782724, "Psilocybin Therapy for Psychological Distress in Palliative Patients". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT06782724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*